Meanwhile, the colony-stimulating factor-1 receptor (CSF-1R) signaling pathway can contribute to the immunosuppressive tumor microenvironment, and its inhibitors are currently being investigated in clinical trials (Riaz et al., 2021). The gene discussed is CSF1R; the disease is neoplasm.